| | Change | 5d. change | 1st Jan change | 1-year change | 3-years change | Capi. (M$) |
 | RECURSION PHARMACEUTICALS, INC. | 0.55% | 12.17% | -46.99% | -76.19% | --.--% | 1 553 |
| | | | | | | |
 | GILEAD SCIENCES, INC. | 0.14% | 0.40% | -13.48% | -8.10% | -6.91% | 78 683 |
 | VERTEX PHARMACEUTICALS | 1.05% | 3.86% | 33.98% | 47.85% | 66.46% | 74 466 |
 | REGENERON PHARMACEUTICALS, INC. | 1.06% | -0.46% | -4.80% | 2.61% | 98.51% | 64 098 |
 | WUXI APPTEC CO., LTD. | -0.39% | 8.70% | -4.67% | -22.59% | 188.09% | 49 112 |
 | BIONTECH SE | 4.08% | 12.83% | -35.33% | -19.04% | --.--% | 38 932 |
 | GENMAB A/S | 1.41% | 6.91% | -6.88% | -8.55% | 107.02% | 21 595 |
 | ARGENX SE | 0.99% | 2.89% | 16.18% | 39.38% | 192.57% | 20 173 |
 | BEIGENE, LTD. | 3.68% | 11.56% | -30.71% | -40.43% | 46.60% | 18 720 |
 | NEUROCRINE BIOSCIENCES, INC. | 0.89% | -3.31% | 12.77% | -2.18% | 14.02% | 9 099 |
 | LEGEND BIOTECH CORPORATION | -0.07% | 4.43% | 21.88% | 44.74% | --.--% | 8 768 |
 | EXELIXIS, INC. | 1.25% | 3.56% | 19.26% | 21.31% | 6.60% | 6 906 |
 | SAREPTA THERAPEUTICS, INC. | 5.07% | -1.43% | -11.35% | 10.88% | -45.43% | 6 647 |
 | HALOZYME THERAPEUTICS, INC. | 7.96% | 1.20% | 25.52% | 10.63% | 195.66% | 6 441 |
 | INTRA-CELLULAR THERAPIES, INC. | 3.12% | -3.67% | 10.66% | 41.27% | 395.04% | 5 298 |
 | SHANGHAI MEDICILON INC. | 2.84% | 14.16% | 11.78% | 39.90% | --.--% | 5 024 |